Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

'Validation and Development of New Dichoptic VR-gaming Method to Treat Childhood Amblyopia; Vedea Amblyopia Therapy (VAT)

NCT05620173 is registered in ClinicalTrials.gov with Vedea Healthware BV as lead sponsor.

NCT NCT05620173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05620173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
'Validation and Development of New Dichoptic VR-gaming Method to Treat Childhood Amblyopia; Vedea Amblyopia Therapy (VAT)
Lead sponsor
Vedea Healthware BV
Phase
Not applicable
Overall status
Unknown status
Start date
February 22, 2023
Completion date
December 1, 2024
Enrollment
74 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

amblyopia, amblyopia strabismic, amblyopia, anisometropic